Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Arthritis Research & Therapy|March 28, 2006
A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese populationTomoko Sugiura, Nobuaki Maeno, Yasushi Kawaguchi, et al.
Clinical Immunology (Orlando, Fla.)|June 24, 2015
Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritisMasaki Shimizu, Yasuo Nakagishi, Natsumi Inoue, et al.
Modern Rheumatology|January 3, 2018
Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in JapanTomohiro Kubota, Syuji Takei, Masaki Shimizu, et al.
Annals of the Rheumatic Diseases|August 20, 2011
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patientsTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
Modern Rheumatology|December 15, 2021
Clinical practice guidance for childhood-onset systemic lupus erythematosus-secondary publicationSyuji Takei, Toru Igarashi, Tomohiro Kubota, et al.
Modern Rheumatology|October 17, 2015
The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatmentYasuhito Nerome, Harumi Akaike, Yukiko Nonaka, et al.
Modern Rheumatology|December 10, 2014
Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in JapanHisashi Yamanaka, Masayoshi Harigai, Naoki Ishiguro, et al.
The Pediatric Infectious Disease Journal|December 10, 2019
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease: A Postmarketing Surveillance in Japan (SAKURA Study)Masaru Miura, Tohru Kobayashi, Toru Igarashi, et al.
Modern Rheumatology|October 8, 2015
Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritisTomohiro Kubota, Hiroyuki Imanaka, Syuji Takei, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|September 25, 2014
Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in KagoshimaYasuhito Nerome, Kanami Kojyo, Yumiko Ninomiya, et al.
Pageof 9